Page last updated: 2024-10-29

isoflurane and Tuberous Sclerosis

isoflurane has been researched along with Tuberous Sclerosis in 2 studies

Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.

Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asano, E1
Benedek, K1
Shah, A1
Juhász, C1
Shah, J1
Chugani, DC1
Muzik, O1
Sood, S1
Chugani, HT1
Nott, MR1
Halfacre, J1

Other Studies

2 other studies available for isoflurane and Tuberous Sclerosis

ArticleYear
Is intraoperative electrocorticography reliable in children with intractable neocortical epilepsy?
    Epilepsia, 2004, Volume: 45, Issue:9

    Topics: Adolescent; Anesthesia, General; Brain Mapping; Child; Child, Preschool; Electrodes, Implanted; Elec

2004
Anaesthesia for dental conservation in a patient with tuberous sclerosis.
    European journal of anaesthesiology, 1996, Volume: 13, Issue:4

    Topics: Adult; Anesthesia, Dental; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; D

1996